American scientists believe that wearable sensors can help diagnose heart rhythm disturbances without interfering with daily activities.
Atrial fibrillation disorders are characterized by an increased heart rate or an unstable heart rate. All these signs can be harbingers of a heart attack, heart failure and a number of other serious diseases. More often than not, people ignore ailments such as short-term pain in the heart, tingling, or a rapid heartbeat. Unfortunately, this behavior is one of the factors that make cardio-diseases the leading cause of death.
The FDA has approved a daily wearable device that performs ECG screening to detect abnormal heart rhythms. He also helps monitor patients who have recently had a heart attack. The device was named Zio Patch and was manufactured by the Californian company iRhythm Technologies.
Stephen Steinhubl, director of digital medicine at Scripps Translational Science in California, argues that early diagnosis of atrial fibrillation can help you quickly begin effective therapy and reduce your risk of heart attack.
Over 4 months of observation, doctors have found that using the wearable Zio Patch devices, you can diagnose heart disorders faster and more accurately. So, out of 1366 patients who wore Zio Patch, signs of cardiac problems were found in 53. In the control group, consisting of 1293 people, experts identified violations by traditional methods and found the initial signs of diseases only in 12.
“The study demonstrates the usefulness of digital technology not only in diagnosing asymptomatic disorders, but also in clinical research in general,” says Professor Steinhubl.
The wearables industry is just beginning to develop, but today there is no doubt that its potential is great. The medicine of the future will be one of the areas where wearables will be widely used.
The Topic of Article: Zio Patch is a wearable sensor that is approved by American doctors.